These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27322058)

  • 1. γ-Secretase inhibitor-resistant glioblastoma stem cells require RBPJ to propagate.
    Fan X
    J Clin Invest; 2016 Jul; 126(7):2415-8. PubMed ID: 27322058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RBPJ maintains brain tumor-initiating cells through CDK9-mediated transcriptional elongation.
    Xie Q; Wu Q; Kim L; Miller TE; Liau BB; Mack SC; Yang K; Factor DC; Fang X; Huang Z; Zhou W; Alazem K; Wang X; Bernstein BE; Bao S; Rich JN
    J Clin Invest; 2016 Jul; 126(7):2757-72. PubMed ID: 27322055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-secretase inhibition reduces human glioblastoma stem cell growth in vitro and in vivo by inhibiting Notch.
    Floyd DH; Kefas B; Seleverstov O; Mykhaylyk O; Dominguez C; Comeau L; Plank C; Purow B
    Neuro Oncol; 2012 Oct; 14(10):1215-26. PubMed ID: 22962413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Farnesyltransferase Potentiates NOTCH-Targeted Therapy against Glioblastoma Stem Cells.
    Ma Y; Cheng Z; Liu J; Torre-Healy L; Lathia JD; Nakano I; Guo Y; Thompson RC; Freeman ML; Wang J
    Stem Cell Reports; 2017 Dec; 9(6):1948-1960. PubMed ID: 29198824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-dependent proteomic analysis of glioblastoma cancer stem cells upon treatment with γ-secretase inhibitor.
    Dai L; He J; Liu Y; Byun J; Vivekanandan A; Pennathur S; Fan X; Lubman DM
    Proteomics; 2011 Dec; 11(23):4529-40. PubMed ID: 21932445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual mTORC1/2 blockade inhibits glioblastoma brain tumor initiating cells in vitro and in vivo and synergizes with temozolomide to increase orthotopic xenograft survival.
    Luchman HA; Stechishin OD; Nguyen SA; Lun XQ; Cairncross JG; Weiss S
    Clin Cancer Res; 2014 Nov; 20(22):5756-67. PubMed ID: 25316808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. γ-Secretase inhibitor I inhibits neuroblastoma cells, with NOTCH and the proteasome among its targets.
    Dorneburg C; Goß AV; Fischer M; Roels F; Barth TF; Berthold F; Kappler R; Oswald F; Siveke JT; Molenaar JJ; Debatin KM; Beltinger C
    Oncotarget; 2016 Sep; 7(39):62799-62813. PubMed ID: 27588497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Notch signaling by γ-secretase inhibitor I enhances the cytotoxic effect of 5-FU in gastric cancer.
    Lee HW; Kim SJ; Choi IJ; Song J; Chun KH
    Clin Exp Metastasis; 2015 Aug; 32(6):593-603. PubMed ID: 26134677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Targeting of the Notch Pathway in Glioblastoma Multiforme.
    Gersey Z; Osiason AD; Bloom L; Shah S; Thompson JW; Bregy A; Agarwal N; Komotar RJ
    World Neurosurg; 2019 Nov; 131():252-263.e2. PubMed ID: 31376551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stattic and metformin inhibit brain tumor initiating cells by reducing STAT3-phosphorylation.
    Leidgens V; Proske J; Rauer L; Moeckel S; Renner K; Bogdahn U; Riemenschneider MJ; Proescholdt M; Vollmann-Zwerenz A; Hau P; Seliger C
    Oncotarget; 2017 Jan; 8(5):8250-8263. PubMed ID: 28030813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
    Hales EC; Taub JW; Matherly LH
    Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of NOTCH Signaling by Tenascin-C Promotes Growth of Human Brain Tumor-Initiating Cells.
    Sarkar S; Mirzaei R; Zemp FJ; Wei W; Senger DL; Robbins SM; Yong VW
    Cancer Res; 2017 Jun; 77(12):3231-3243. PubMed ID: 28416488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of the notch signaling pathway by γ-secretase inhibitor GSI inhibits human nasopharyngeal carcinoma cell proliferation.
    Chen SM; Liu JP; Zhou JX; Chen C; Deng YQ; Wang Y; Tao ZZ
    Cancer Lett; 2011 Jul; 306(1):76-84. PubMed ID: 21420785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RBPJ is a novel target for rhabdomyosarcoma therapy.
    Nagao H; Setoguchi T; Kitamoto S; Ishidou Y; Nagano S; Yokouchi M; Abematsu M; Kawabata N; Maeda S; Yonezawa S; Komiya S
    PLoS One; 2012; 7(7):e39268. PubMed ID: 22792167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative genomic and genetic analysis of glioblastoma-derived brain tumor-initiating cells and their parent tumors.
    Davis B; Shen Y; Poon CC; Luchman HA; Stechishin OD; Pontifex CS; Wu W; Kelly JJ; Blough MD;
    Neuro Oncol; 2016 Mar; 18(3):350-60. PubMed ID: 26245525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GSI-I has a better effect in inhibiting hepatocellular carcinoma cell growth than GSI-IX, GSI-X, or GSI-XXI.
    Shen Y; Lv D; Wang J; Yin Y; Miao F; Dou F; Zhang J
    Anticancer Drugs; 2012 Aug; 23(7):683-90. PubMed ID: 22569108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Notch inhibition restores TRAIL-mediated apoptosis via AP1-dependent upregulation of DR4 and DR5 TRAIL receptors in MDA-MB-231 breast cancer cells.
    Portanova P; Notaro A; Pellerito O; Sabella S; Giuliano M; Calvaruso G
    Int J Oncol; 2013 Jul; 43(1):121-30. PubMed ID: 23686163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinogen in the glioblastoma microenvironment contributes to the invasiveness of brain tumor-initiating cells.
    Dzikowski L; Mirzaei R; Sarkar S; Kumar M; Bose P; Bellail A; Hao C; Yong VW
    Brain Pathol; 2021 Sep; 31(5):e12947. PubMed ID: 33694259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting atypical protein kinase C iota reduces viability in glioblastoma stem-like cells via a notch signaling mechanism.
    Phillips E; Lang V; Bohlen J; Bethke F; Puccio L; Tichy D; Herold-Mende C; Hielscher T; Lichter P; Goidts V
    Int J Cancer; 2016 Oct; 139(8):1776-87. PubMed ID: 27299852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. γ-secretase inhibitor-I enhances radiosensitivity of glioblastoma cell lines by depleting CD133+ tumor cells.
    Lin J; Zhang XM; Yang JC; Ye YB; Luo SQ
    Arch Med Res; 2010 Oct; 41(7):519-29. PubMed ID: 21167391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.